After giving exemption, NPPA asks Meril Life Sciences for MRP of its stent Medical Dialogues Bureau8 March 2020 9:59 AM GMTNew Delhi: Just days after giving exemption to cardiac stent maker Meril Life Sciences, the apex drug price regulator has asked the company to inform...
Meril Life Sciences gets 5 years exemption from NPPA for its MeRes100 stent Medical Dialogues Bureau1 March 2020 5:30 AM GMTNew Delhi: The national pharmaceutical regulator NPPA has exempted a new coronary stent developed by Meril Life Sciences from price control for five...
With questions about safety of Meril's Made in India BVS stent, NPPA defers its appeal for price exemption Medical Dialogues Bureau21 Nov 2019 6:39 AM GMTNew Delhi: With an industry association raising health and safety concerns about the flagship Sirolimus-Eluting BioResorbable vascular scaffold system...
Should Next Gen DES Stents be removed from Price Cap- Govt Panel to Decide Farhat Nasim10 Aug 2019 11:21 AM GMTNEW DELHI: In a bid to re-enter the market with advanced drug-eluting stents (DES), various medical device makers are in talks with the Government to...
Meril Life Sciences gets European Conformity mark for Bioresorbable Scaffold MeRes100 Medical Dialogues Bureau9 Aug 2019 4:15 AM GMTMeril Life Sciences MeRes100 has received both Drug Controller General of India(DCGI) and CE (European Conformity) marketing approval. New Delhi:...
Setback to Meril Lifesciences MeRess100: NPPA refuses to give relief of price cap exemption for the biodegradable stent Meghna A Singhania5 March 2019 11:31 AM GMTNew Delhi: In a major setback to Meril Lifesciences, the drug price regulator National Pharmaceutical Pricing Authority(NPPA) has refused to give it...
NPPA to decide on Merrills Request for price cap exemption for its biodegradable stent Meghna A Singhania3 Feb 2019 5:46 AM GMTNew Delhi: A Year after Abbott's launch of biodegradable stents which was later withdrawn globally, Meril Life Sciences has moved the National...
